Encompass Health (NYSE: EHC) director awarded 40 RSUs on dividend

Rhea-AI Filing Summary

Encompass Health Corp director Nancy M. Schlichting reported an automatic award of 40 shares of Encompass Health common stock on January 15, 2026. The shares were credited at a price of $0.00 per share as restricted stock units tied to the company’s common stock dividend. The footnote explains that non-employee directors receive additional RSUs whenever dividends are paid, based on the number of existing RSUs, the per-share dividend of $0.19, and the closing price of $102.80 on the dividend payment date. Following this transaction, Schlichting beneficially owned 21,259 shares of Encompass Health common stock in direct form.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SCHLICHTING NANCY M

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	01/15/2026		A		40(1)	A	$0	21,259	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $102.80. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

	/s/ Patrick Darby, attorney-in-fact for Nancy M. Schlichting	01/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Encompass Health (EHC) director Nancy Schlichting report?

Director Nancy M. Schlichting reported receiving 40 shares of Encompass Health common stock on January 15, 2026. The transaction was coded as an acquisition at $0.00 per share, reflecting an automatic credit of dividend-related restricted stock units.

Why did Nancy Schlichting receive 40 RSUs from Encompass Health (EHC)?

The footnote states that non-employee directors receive additional restricted stock units (RSUs) when Encompass Health pays common stock dividends. On January 15, 2026, the company paid a $0.19 per share dividend and the stock closed at $102.80, resulting in an award of 40 RSUs to her account.

How many Encompass Health (EHC) shares does Nancy Schlichting own after this Form 4 transaction?

After the reported transaction, Nancy M. Schlichting beneficially owned 21,259 shares of Encompass Health common stock. The ownership is reported as direct.

What role does Nancy Schlichting hold at Encompass Health (EHC)?

The Form 4 identifies Nancy M. Schlichting as a director of Encompass Health Corp. She is not listed as an officer or a 10% owner in this filing.

How are dividend-equivalent RSUs calculated for Encompass Health (EHC) directors?

According to the footnote, the number of RSUs credited equals (RSUs held on the dividend record date × per-share dividend) ÷ closing stock price on the dividend payment date. This formula produced 40 RSUs for Nancy Schlichting based on the $0.19 dividend and $102.80 closing price.

Was the Encompass Health (EHC) Form 4 transaction a market purchase or sale?

No market trade was reported. The Form 4 shows an acquisition (Code A) of 40 shares at $0.00 per share, representing an automatic award of dividend-equivalent RSUs rather than an open-market purchase or sale.